Dr. Chi

Dr. Chi received his chemistry degree from Chung-Yuan College of Science and Engineer in Taiwan, Rep. of China, and earned his Ph.D. in Biochemistry from Rutgers University at the prestigious Waksman Institute of Microbiology in New Jersey, the institute was named for Selman A. Waksman, winner of the 1952 Nobel Prize for Physiology or Medicine. Where he was one of five Ph. D. students chosen for the Charles and Johanna Busch Memorial Pre-Doctoral Fellowship. Even before his thesis defense, he was already hired by E.R. Squibb and Sons, Inc. New Jersey, to work on their Infectious Disease program as Research Group Leader in the Microbial Biochemistry Department. He later moved to Warner Lambert/Parke-Davis Co. in Michigan where he started working in Cancer Screening. He was the Senior Group Leader of Antibiotics and Anticancer Chemotherapy Department.

In 1983, Dr. Chi moved to California to be the Laboratory Director of Omicron Incorporated in Redlands. He was involved in the fields of cancer and atherosclerosis and was closely associated with the late Virginia Livingston, MD. While at Omicron, Dr. Chi developed a California state licensed Neostop® Anti-Tumor Vaccine for poultry. He also obtained a patient for the detection of antibodies against a chorionic gonadotropin-like substance. Because of his extraordinary accomplishment, in 1983, Dr. Chi was selected by the government of Rep. of China, to present a series lectures in the first Biotechnology Meeting of National Construction Committee (國建會), where 15 people were elected nationwide. In 1986, Dr. Chi founded his own company, Chi’s Enterprise, Inc in California. He then became a board-certified Naturopathic Medical Doctor.

For over 30 years now, Dr. Chi has been dedicated to providing innovative and natural remedies through his company to many doctors and patients. He is also a sought-after lecturer and keynote speaker at various medical conventions around the world. To date, Dr. Chi has given over 200 lectures in various countries, including the United States, China, Taiwan, Mexico and the Philippines. He has also given Board-Approved for Continuing Education courses sponsored by the American Naturopathic Medical Association, American College for Advancement in Medicine, Philippine College for Advancement in Medicine, Orthomolecular Health Medicine Society, Cancer Control Society, Parker Chiropractic College, Alaska Chiropractic Society, Florida Chiropractic Physicians Association, Michigan Association of Chiropractors, Texas College of Chiropractic, American Chiropractic Association Council on Nutrition, and California Chiropractic Association, among others. Dr. Chi has formulated over 40 different natural supplements that are based on cutting edge science. Noted physicians and personalities have been using his natural supplements for years. One of his supplements, Angiostop, which inhibits angiogenesis and receptor tyrosine kinase (RTK) and activates caspases for cancer apoptosis. The Research Genetic Cancer Centre (RGCC) includes Angiostop as one of the standard from natural substances they routinely test against cancer cells. Another of his supplement, Myomin, is the only natural supplement proven to reduce aromatase expression and is recommended for estrogen-dominant conditions. It has been discussed in over 20 Bioidentical Hormone Replacement Therapy (BHRT) conventions.

Dr. Ho

In addition to serving as a certified and board member in many professional associations in Taiwan, Dr. Ho also devoted to medical education and research ethics as exemplified by serving the Dean of medical school for 6 years and president and chairman of Medical Research Ethics Foundation of JIRB since 1995. Dr. Ho is also a member of the American Diabetes Association, the Endocrine Society USA, and the American Federation for Clinical Research. Besides, he is enthusiastically involved as reviewer or member of editorial board for numerous international professional scientific journals in the fields of medicine, nutrition, and pharmacology, etc.. Although his many appointments keep him busy, Dr. Ho’s primary research interests are in the areas of insulin resistance and endothelin-1, diabetes and obesity, hypertension and coronary disease. To date, he and his research team have published more than 330 research articles and reviews.   

Areas of expertise: Diabetes, Insulin Resistance, Obesity, Hypertension, Endothelin-1, Diabetic Complications, Adipocytes, Lipid Metabolism, Nutrition, and Research Ethics.

Dr. Wycoff

Dr. Wycoff is a graduate of Morningside College in Sioux City, Iowa with majors in biology and chemistry.  He completed medical school at the Kirksville College of Osteopathic Medicine matriculating in 1985.  He performed a one-year rotating internship at Metropolitan Hospital in Grand Rapids and completed his family medicine residency, serving as chief resident, at Sparrow Hospital in Lansing, Michigan.

Dr. Wycoff is board certified in family medicine by both the American Medical Association and the American Osteopathic Association.  He has been a physician leader in Lansing serving as the elected Chief of Staff of both St. Lawrence and Sparrow Hospitals in Lansing.  He has served in a number of medical staff leadership positions at both hospitals.

Dr. Wycoff is a member of a number of professional organizations including the American College for the Advancement of Medicine, The Institute of Functional Medicine and the Pan American Allergy Society.  He is a current board member and past president of the Pan American Allergy Society.

Dr. Yamamoto